Atsuo Sasaki, Ph.D., associate professor at the UC College of Medicine, says there's an FDA-approved drug that can shrink brain and other types of inoperable cancer in animal models by targeting the energy production mechanism of cancerous cells.
A new cancer drug previously reported on by WVXU has been green-lighted for a Phase 1 study on children. BXQ-350 is manufactured by Bexion Pharmaceuticals in Covington and was developed at Cincinnati Children's Hospital Medical Center, where it will be tested on children with solid tumors, brain tumors and diffuse intrinsic pontine gliomas (DIPG), a type of brain tumor.
A promising new cancer drug developed at Cincinnati Children's Hospital Medical Center and manufactured by Bexion Pharmaceuticalsin Covington will soon be tested on children. BXQ-350 is already showing signs it's working on adults who have brain and gastrointestinal tumors.
The family of terminal cancer patient Brody Allen say they have found a whole new family thanks to the generosity and love of the Tri-State. Sunday afternoon, more than 1,000 people traveled to Colerain Township to either be in or watch the Christmas-themed parade held in the 2-year-old's honor.
President Trump has signed into law a bipartisan bill aimed at investigating the high cancer rate among firefighters. The president of the Ohio Association of Professional Firefighters says it’s needed.
African-Americans have the highest mortality rate for all cancers combined. The disease is the second-leading cause of death among Native Americans over 45. Asian-Americans have the highest rates of liver and stomach cancers. While Hispanics and Latinos have lower incidence and death rates for most common cancers than whites, they are more likely to be diagnosed with advanced stages of disease.
Cincinnati Children’s Hospital will soon be getting a newly-approved drug that uses the body’s own immune system to fight cancer. Kymriah, as it’s known, gives new hope to the families of kids with leukemia.